In a recent announcement from Paris, France’s Finance Minister Antoine Armand confirmed that the Public Investment Bank (BPI) will acquire a 1% stake in Opella, a subsidiary of Sanofi, for approximately 150 million euros ($162.98 million). This development follows a report from Le Figaro detailing a major transaction where U.S. private equity firm Clayton Dubilier...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
